Rallybio Corporation Announces New Employment Agreement with Chief Medical Officer, Steven Ryder, Including Enhanced Compensation and Benefits Package
Rallybio Corporation has announced a new employment agreement with its Chief Medical Officer, Dr. Steven Ryder, effective June 25, 2025. Under this agreement, Dr. Ryder will receive an annual base salary of $531,227 and will be eligible for an annual target bonus of up to 40% of his salary, contingent upon meeting individual and company performance goals. The agreement stipulates an initial one-year term, automatically renewing for successive one-year terms unless either party provides a 60-day notice to terminate. In the event of termination following a change in control, Dr. Ryder will be entitled to severance benefits including a 1.5 times payment of his annual salary and target bonus, plus health premium coverage, and immediate vesting of certain equity awards.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rallybio Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001739410-25-000093), on June 27, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。